Fjarde Ap-fonden’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.8M	Buy	346,104 +54,300	+19%	+$910K	0.05%	304
2025 Q1	$4.49M	Sell	291,804 -19,339	-6%	-$297K	0.05%	322
2024 Q4	$6.86M	Buy	311,143 +7,193	+2%	+$159K	0.07%	265
2024 Q3	$5.48M	Buy	+303,950	New	+$5.48M	0.06%	325
2024 Q1	$5.2M	Buy	368,323 +6,268	+2%	+$88.4K	0.06%	335
2023 Q4	$3.78M	Buy	362,055 +10,885	+3%	+$114K	0.05%	397
2023 Q3	$3.58M	Buy	351,170 +18,519	+6%	+$189K	0.05%	393
2023 Q2	$2.51M	Buy	332,651 +174,700	+111%	+$1.32M	0.03%	461
2023 Q1	$1.4M	Sell	157,951 -32,549	-17%	-$288K	0.02%	487
2022 Q4	$1.74M	Sell	190,500 -159,500	-46%	-$1.45M	0.02%	474
2022 Q3	$2.63M	Hold	350,000	–	–	0.03%	468
2022 Q2	$2.63M	Hold	350,000	–	–	0.03%	468
2022 Q1	$3.29M	Hold	350,000	–	–	0.03%	471
2021 Q4	$2.8M	Buy	350,000 +150,000	+75%	+$1.2M	0.02%	510
2021 Q3	$1.95M	Hold	200,000	–	–	0.02%	539
2021 Q2	$1.98M	Hold	200,000	–	–	0.02%	550
2021 Q1	$2.31M	Hold	200,000	–	–	0.02%	540
2020 Q4	$1.93M	Hold	200,000	–	–	0.02%	549
2020 Q3	$1.8M	Hold	200,000	–	–	0.02%	562
2020 Q2	$2.47M	Hold	200,000	–	–	0.03%	491
2020 Q1	$1.8M	Hold	200,000	–	–	0.03%	499
2019 Q4	$1.96M	Hold	200,000	–	–	0.02%	565
2019 Q3	$1.38M	Hold	200,000	–	–	0.02%	569
2019 Q2	$1.85M	Hold	200,000	–	–	0.02%	549
2019 Q1	$3.14M	Hold	200,000	–	–	0.04%	450
2018 Q4	$3.08M	Hold	200,000	–	–	0.05%	363
2018 Q3	$4.31M	Hold	200,000	–	–	0.06%	347
2018 Q2	$4.86M	Buy	+200,000	New	+$4.86M	0.07%	291